Why the study?
Does discontinuing or reducing antihypertensive drug treatment maintain normotension compared to continuing treatment in male hypertensive patients with controlled BP?
Does discontinuing or reducing antihypertensive drug treatment maintain normotension compared to continuing treatment in male hypertensive patients with controlled BP?
Decreasing antihypertensive drug dosages is an effective method for maintaining blood pressure control while minimizing side effects and costs, whereas complete discontinuation often leads to elevated blood pressure.
Answers are grounded in this paper and cite their sources.
Supports HCTZ dose reduction over discontinuation for sustained BP control; extends RCT evidence for deprescribing in stable hypertension.
The possibility of discontinuing--compared to reducing--antihypertensive drug treatment was investigated in 606 male hypertensive patients with entry diastolic blood pressure (BP) in the range of 90 to 114 mm Hg. Diastolic BP was controlled at less than 90 mm Hg with 1 of 4 regimens: low dose hydrochlorothiazide (HCTZ), 25 mg twice daily; high dose HCTZ, 50 mg twice daily; or high dose HCTZ plus a low or high dose of a step II drug (propranolol, clonidine or reserpine). After 6 months of treatment that controlled BP, dosages were reduced in two-thirds of the patients. In those patients receiving low dose HCTZ and randomized to dose reduction, antihypertensive drugs were completely discontinued. Although approximately half of these patients remained normotensive for the first 6 months, a significantly greater proportion had elevation of BP compared to the control group, which continued to receive treatment (p less than 0.0001). In the high dose HCTZ drug group, the proportion of patients remaining normotensive did not differ among those stepped down to low dose HCTZ and the fully treated control group. While not achieving significance the trend was similar with the step II regimens. Although some patients remained normotensive after discontinuation of step II drugs, a greater proportion returned to elevated BP than when step II dosage was unchanged. Therefore, while stopping therapy may be effective in some patients, a decreased dosage is significantly more effective as a method for maintaining an antihypertensive effect. Decreasing drug dosages offers the dual benefit of minimizing side effects and reducing drug costs.
No takes yet. Share an insight, caveat, or question.
Freis et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: